Hemant M. Vishwasrao

Hemant M. Vishwasrao

Auto-generated profile, based on publicly available information

Hemant M. Vishwasrao

Center for Nanotechnology in Drug Delivery and Division of Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2015 in Nanomedicine: Nanotechnology, Biology and Medicine
Verified
Journal Article
Closed access
Maxim AbakumovMaxim Abakumov
Maxim Abakumov
NNNatalia V. Nukolova
Natalia V. Nukolova
MSMarina Sokolsky-Papkov
Marina Sokolsky-Papkov
SSSergey A. Shein
Sergey A. Shein
TSTatiana O. Sandalova
Tatiana O. Sandalova
VCVladimir Chehonin
Vladimir Chehonin

20 September 2016 in Scientific Reports
Verified
Journal Article
Open access
PDF file
AMAlyssa M Master
Alyssa M Master
PWPhilise N Williams
Philise N Williams
NPNikorn Pothayee
Nikorn Pothayee
NPNipon Pothayee
Nipon Pothayee
RZRui Zhang
Rui Zhang
AKAlexander Kabanov
Alexander Kabanov
Motion of micron and sub-micron size magnetic particles in alternating magnetic fields can activate mechanosensitive cellular functions or physically destruct cancer cells. However, such effects are usually observed with relatively large magnetic particles (>250 nm) that would be difficult if at all possible to deliver to remote sites in the body to treat disease. Here we show a completely new mechanism of selective toxicity of superparamagnetic nanoparticles (SMNP) of 7 to 8 nm in diameter to cancer cells. These particles are coated by block copolymers, which facilitates their entry into the cells and clustering in the lysosomes, where they are then magneto-mechanically actuated by remotely applied alternating current (AC) magnetic fields of very low frequency (50 Hz). Such fields and treatments are safe for surrounding tissues but produce cytoskeletal disruption and subsequent death of cancer cells while leaving healthy cells intact.

1 September 2019 in Journal of Colloid and Interface Science
Verified
Journal Article
Closed access
KVKseniya Yu. Vlasova
Kseniya Yu. Vlasova
APAlexander Piroyan
Alexander Piroyan
Irina M. Le-DeygenIrina M. Le-Deygen
Irina M. Le-Deygen
HVHemant M. Vishwasrao
Hemant M. Vishwasrao
JRJacob D. Ramsey
Jacob D. Ramsey
MSMarina Sokolsky-Papkov
Marina Sokolsky-Papkov

1 March 2014 in Nanomedicine
Verified
Journal Article
Closed access
DSDhirender Singh
Dhirender Singh
JMJoEllyn M McMillan
JoEllyn M McMillan
XLXin-Ming Liu
Xin-Ming Liu
HVHemant M Vishwasrao
Hemant M Vishwasrao
AKAlexander Kabanov
Alexander Kabanov
HGHoward E Gendelman
Howard E Gendelman
Magnetic nanoparticles (MNPs) accumulate at disease sites with the aid of magnetic fields; biodegradable MNPs can be designed to facilitate drug delivery, influence disease diagnostics, facilitate tissue regeneration and permit protein purification. Because of their limited toxicity, MNPs are widely used in theranostics, simultaneously facilitating diagnostics and therapeutics. To realize therapeutic end points, iron oxide nanoparticle cores (5–30 nm) are encapsulated in a biocompatible polymer shell with drug cargos. Although limited, the toxic potential of MNPs parallels magnetite composition, along with shape, size and surface chemistry. Clearance is hastened by the reticuloendothelial system. To surmount translational barriers, the crystal structure, particle surface and magnetic properties of MNPs need to be optimized. With this in mind, we provide a comprehensive evaluation of advancements in MNP synthesis, functionalization and design, with an eye towards bench-to-bedside translation.

2 May 2016 in Chemistry of Materials
Verified
Journal Article
Closed access
HVHemant M. Vishwasrao
Hemant M. Vishwasrao
AMAlyssa M. Master
Alyssa M. Master
YSYoun Gee Seo
Youn Gee Seo
XLXinming M. Liu
Xinming M. Liu
NPNikorn Pothayee
Nikorn Pothayee
AKAlexander Kabanov
Alexander Kabanov

16 March 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
KVKseniya Yu. Vlasova
Kseniya Yu. Vlasova
HVHemant Vishwasrao
Hemant Vishwasrao
Maxim AbakumovMaxim Abakumov
Maxim Abakumov
DGDmitry Yu. Golovin
Dmitry Yu. Golovin
SGSergey L. Gribanovsky
Sergey L. Gribanovsky
AKAlexander Kabanov
Alexander Kabanov
Remote nano-magneto-mechanical actuation of magnetic nanoparticles (MNPs) by non-heating extremely low frequency magnetic field (ELF MF) is explored as a tool for non-invasive modification of bionanomaterials in pharmaceutical and medical applications. Here we study the effects of ELF MF (30–160 Hz, 8–120 kA/m) on the activity and release of a model enzyme, superoxide dismutase 1 (SOD1) immobilized by polyion coupling on dispersed MNPs aggregates coated with poly(L-lysine)-block-poly(ethylene glycol) block copolymer (s-MNPs). Such fields do not cause any considerable heating of MNPs but promote their rotating-oscillating mechanical motion that produces mechanical forces and deformations in adjacent materials. We observed the changes in the catalytic activity of immobilized SOD1 as well as its release from the s-MNPs/SOD1 polyion complex upon application of the ELF MF for 5 to 15 min. At longer exposures (25 min) the s-MNPs/SOD1 dispersion destabilizes. The bell-shaped effect of the field frequency with maximum at f = 50 Hz and saturation effect of field strength (between 30 kA/m and 120 kA/m at f = 50 Hz) are reported and explained. The findings are significant as one early indication of the nano-magneto-mechanical disruption by ELF MF of cooperative polyion complexes that are widely used for design of current functional healthcare bionanomaterials.